CN106465946A - A kind of loosening bowel to relieve constipation dietary fiber - Google Patents
A kind of loosening bowel to relieve constipation dietary fiber Download PDFInfo
- Publication number
- CN106465946A CN106465946A CN201610833210.8A CN201610833210A CN106465946A CN 106465946 A CN106465946 A CN 106465946A CN 201610833210 A CN201610833210 A CN 201610833210A CN 106465946 A CN106465946 A CN 106465946A
- Authority
- CN
- China
- Prior art keywords
- dietary fiber
- weight portion
- loosening bowel
- relieve constipation
- inulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010010774 Constipation Diseases 0.000 title claims abstract description 64
- 235000013325 dietary fiber Nutrition 0.000 title claims abstract description 49
- 239000000843 powder Substances 0.000 claims abstract description 41
- 229920001202 Inulin Polymers 0.000 claims abstract description 40
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 40
- 229940029339 inulin Drugs 0.000 claims abstract description 40
- 241000219780 Pueraria Species 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 235000013305 food Nutrition 0.000 claims abstract description 16
- 239000003826 tablet Substances 0.000 claims abstract description 15
- 239000002775 capsule Substances 0.000 claims abstract description 12
- 239000008187 granular material Substances 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 238000004891 communication Methods 0.000 claims description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 10
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 9
- 229940013618 stevioside Drugs 0.000 claims description 9
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 9
- 235000019202 steviosides Nutrition 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 229920000151 polyglycol Polymers 0.000 claims description 6
- 239000010695 polyglycol Substances 0.000 claims description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 5
- 210000002784 stomach Anatomy 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 claims description 3
- 244000290333 Vanilla fragrans Species 0.000 claims description 3
- 235000009499 Vanilla fragrans Nutrition 0.000 claims description 3
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 239000007888 film coating Substances 0.000 claims description 3
- 238000009501 film coating Methods 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 240000008790 Musa x paradisiaca Species 0.000 claims description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 239000007963 capsule composition Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 1
- 229960003943 hypromellose Drugs 0.000 claims 1
- 229960002900 methylcellulose Drugs 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
- 239000002023 wood Substances 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 21
- 230000013872 defecation Effects 0.000 abstract description 17
- 239000000203 mixture Substances 0.000 abstract description 12
- 238000005516 engineering process Methods 0.000 abstract description 9
- 210000000936 intestine Anatomy 0.000 abstract description 8
- 210000003608 fece Anatomy 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 abstract description 2
- 230000004206 stomach function Effects 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 229960004192 diphenoxylate Drugs 0.000 description 10
- 238000003304 gavage Methods 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- HYPPXZBJBPSRLK-UHFFFAOYSA-N diphenoxylate Chemical compound C1CC(C(=O)OCC)(C=2C=CC=CC=2)CCN1CCC(C#N)(C=1C=CC=CC=1)C1=CC=CC=C1 HYPPXZBJBPSRLK-UHFFFAOYSA-N 0.000 description 7
- 210000000582 semen Anatomy 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000000976 ink Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- -1 ferment Substances 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 230000008485 antagonism Effects 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002550 fecal effect Effects 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000005180 public health Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 241000219193 Brassicaceae Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 241000801118 Lepidium Species 0.000 description 2
- 240000000759 Lepidium meyenii Species 0.000 description 2
- 235000000421 Lepidium meyenii Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229920000715 Mucilage Polymers 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 244000134552 Plantago ovata Species 0.000 description 2
- 235000003421 Plantago ovata Nutrition 0.000 description 2
- 239000009223 Psyllium Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 235000012902 lepidium meyenii Nutrition 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229940070687 psyllium Drugs 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010002153 Anal fissure Diseases 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010050012 Bradyphrenia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013486 Distractibility Diseases 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010036774 Proctitis Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116364 hard fat Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000000112 undernutrition Nutrition 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kind of loosening bowel to relieve constipation dietary fiber, circle bud Cillium 70～90 weight portion, inulin 5～20 weight portion, pueraria root powder 1～10 weight portion；Acceptable carrier on food can also be included；The loosening bowel to relieve constipation dietary fiber of the present invention, with circle bud Cillium, inulin and pueraria root powder as raw material, after subtle powder smash technology, then adds food stage adjuvant and makes solid granules, capsule and tablet.Proportioning raw materials selected by the present invention meet modern health preserving principle, scientific formulation is reasonable, defecation time can substantially be shortened, promote the motion of small intestinal, increase feces discharge quantity and defecation weight, have and improve human intestines and stomach's function, loosening bowel to relieve constipation, the effects such as regulating intestinal canal health, and good mouthfeel, unique flavor.
Description
Technical field
The present invention relates to a kind of loosening bowel to relieve constipation dietary fiber, belong to food processing technology field.
Background technology
Constipation is clinical common complicated symptom, is primarily referred to as defecation frequency minimizing, feces amount reduces, feces are dry and hard, row
Just laborious etc..Mainly due to lacking cellulose and large quantity of moisture in human body, cause gastrointestinal peristalsiss not normal, metabolite in intestinal,
The harmful substances such as antibacterial can not be discharged in time, often can cause coronary heart disease, hypertension, asthma, the weak, symptom such as bitter taste, irritability.Just
Secret such as more than 6 months be chronic constipation.Prevalence in crowd for the constipation is up to 27%, China have 70,000,000 people be subject to chronic just
Secret torment, old people, women and child are then common, and women is more than male, and old age is more than the blue or green, prime of life.
Can cause during constipation of old people have blood in stool, hemorrhoid, anal fissure, proctitis, rectal cancer, cerebrovascular, coronary heart disease, cardiac muscle stalk
Plug, apoplexy, numb limbs and tense tendons, inappetence.Show according to data, serious constipation person about 10% suffers from colon cancer, this is probably because of constipation
And caused by so that enteral carcinogen can not be discharged for a long time.During constipation, the harmful substance of enteral, it is also possible to interference brain function, is dashed forward
Going out performance is hypomnesis, distractibility, bradyphrenia etc..Serious constipation even occurs the fear to defecation for the old man
Psychology or psychological problem.Therefore, develop product low in calories, high dietary fiber content, improve the balanced diet of people, just become
One trend of social life development.
Circle bud Semen Plantaginiss also known as foreign Herba Plantaginiss (Psyllium), be a kind of medical herbs of Ginuceae section, originate in India, she
Bright, in Mediterranean Region country, also there is cultivation in states such as France, Spain.Circle bud psyllium husk dietary fibre is extremely rich
Richness, rich in compositions such as aucubin (Aucubine), ferment, fat, mucilages (Mucilage).Circle bud Semen Plantaginis shell 2014
New resource food is approved as by China's Ministry of Public Health.Clinical and experimental study shows that circle bud Semen Plantaginiss have following effect：First, promote intestinal
The generation wriggle, help defecation, reducing constipation, promotes that abdominal pressure is normal, improve Developmental Venous Anomalies, also can reduce harmful bacteria generate, fall
The attack rate of low colorectal cancer；2nd, increase feces volume, make intestinal tube intrinsic pressure normal, reduce diverticulosiss, the generation of hemorrhoid；3rd, take circle
Luxuriant Semen Plantaginis powder, can increase satiety, outside minimizing appetite, and then control body weight etc..
Inulin (Inulin), also known as inulin, is the feature poly fruit with tuberous plant Herba Cichorii for Raw material processing
Sugar, is about polymerized by 31 beta-D-fructofuranoses and 1～2 pyrans inulin residue, is also the most diffluent aqueous soluble dietary
Fiber.Inulin, as a kind of functional ingredient of pure natural, is nutritional supplement by more than 20, world state approval, extensively transports
For in milk product, beverage, low-fat low-calorie food, baked food, health food.Inulin is ratified for 2009 by China's Ministry of Public Health
For new resource food, clinical and experimental study shows that inulin has regulating intestinal canal microorganism species, improves intestinal health, prevent just
Secret；Adjust the intestines and stomach, reduce heat, auxiliary blood glucose reduction and control the different physiological roles such as blood fat.
Lepidinm meyenii Walp, makees Maca (Maca, Lepidium meyemii Walp) again, belongs to Cruciferae (Cruciferae) solely Xing
A kind of plant of Lepidium, is pure natural health-care, originates in the South America Andes of 3500～4500 meters of height above sea level in the middle part of Peru
Area, locals, mainly as available food, is alternatively arranged as conventional medicament and uses.Save Lijing, Xishuangbanna in Yunnan Province of China at present
Successfully plant in place, belong to pure natural plant.Since nineteen eighty-two, plantation and edible agate are recommended to various countries by FAO (Food and Agriculture Organization of the United Nation)
Coffee, and point out that Lepidinm meyenii Walp is a kind of nutrient safe food, the health problem that multiple undernutritions cause can be solved.2011 by me
State's Ministry of Public Health is approved as new resource food.Lepidinm meyenii Walp is that a kind of body that can give people provides the natural food resource of full nutrition material.
Lepidinm meyenii Walp has the effects such as resisting fatigue, endocrine regulation.
Chinese patent CN 105211687 A in literature query at present《A kind of compositionss and preparation method thereof are worked in coordination with purposes
Effect》Middle it is pulverized and mixed using oligomeric xylose, circle bud Semen Plantaginis shell, Citrus dietary cellulose, Herba Hordei Vulgariss, water soluble dietary fiber
It is obtained, needed raw material is many, and production technology is complex.Chinese patent CN 105796662 A《A kind of circle bud Cillium with
Inulin composition with functions》Middle employing circle bud Cillium and inulin, as raw material, prepare tablet, coated tablet by complicated technique
More than 20 preparation such as agent, film coated tablet.It is low all to there is effective bioactive molecule bioavailability in above-mentioned patent, and health-care effect is lived
The problems such as property is high.This patent can solve this technical problem, has no at present using superfine communication technique processing circle bud Semen Plantaginiss
Shell powder, inulin and pueraria root powder prepare the report of loosening bowel to relieve constipation dietary fiber.
Content of the invention
Purpose：For solving the deficiencies in the prior art, the present invention provides a kind of loosening bowel to relieve constipation dietary fiber, with through superfine powder
The circle bud Cillium of broken technology, inulin and pueraria root powder prepare loosening bowel to relieve constipation dietary fiber for raw material, and the method is circle bud car
The deep processing of front son and inulin provides new developing direction, improves loosening bowel to relieve constipation dietary fiber deep processing production technology level,
Abundant loosening bowel to relieve constipation diet fiber product kind, problem present in effectively solving loosening bowel to relieve constipation dietary fiber technology of preparing.
Technical scheme：For solving above-mentioned technical problem, the technical solution used in the present invention is：
A kind of loosening bowel to relieve constipation dietary fiber, active component includes circle bud Cillium, inulin, pueraria root powder, weight proportion
For：Circle bud Cillium 70～90 weight portion；Inulin 5～20 weight portion；Pueraria root powder 1～10 weight portion.Described circle bud Herba Plantaginis
Sub- shell powder, inulin, Lepidinm meyenii Walp powder raw material are all processed through superfine communication technique.
Preferably, described loosening bowel to relieve constipation dietary fiber it is characterised in that：Former including following components by weight percent
Material：Circle bud Cillium 85 weight portion, inulin 12 weight portion, pueraria root powder 3 weight portion.
Loosening bowel to relieve constipation dietary fiber of the present invention, can also include acceptable carrier on food；For oral administration
The dosage form of approach, including solid granules (ultra-fine powder), tablet, capsule or oral liquid etc..
Loosening bowel to relieve constipation dietary fiber of the present invention, the formula of solid granules：
Circle bud Cillium：70～90 weight portions
Inulin：5～20 weight portions
Pueraria root powder：1～10 weight portion
Sweeting agent：0.1～2.5 weight portion
Edible essence 0.01-1.0 part weight portion.
Wherein, described sweeting agent is selected from：One or more of stevioside, xylitol, white sugar, aspartame；Described
Edible essence is selected from：One or more of apple essence, flavoring pineapple essence, vanilla, Fructus Citri tangerinae essence, flavoring banana essence.
Loosening bowel to relieve constipation dietary fiber of the present invention, the formula of capsule is：
Circle bud Cillium：70～90 weight portions
Inulin：5～20 weight portions
Pueraria root powder：1～10 weight portion
Magnesium stearate：1～5 weight portion.
Loosening bowel to relieve constipation dietary fiber of the present invention, the formula of its tablet：
Circle bud Cillium：70～90 weight portions
Inulin：5～20 weight portions
Pueraria root powder：1～10 weight portion
Binding agent：20～60 weight portions
Disintegrating agent：1～10 weight portion
Lubricant：1～5 weight portion.
Wherein, described adhesive is Microcrystalline Cellulose, cross-linking sodium carboxymethyl cellulose, sodium carboxymethyl cellulose, hydroxypropyl first
One or more of cellulose, low-substituted hydroxypropyl cellulose, methylcellulose and ethyl cellulose.
Wherein, described disintegrating agent be dried starch, carboxymethyl starch sodium, low-substituted hydroxypropyl cellulose, cross-linked carboxymethyl fine
One or more of plain sodium of dimension.
Wherein, described lubricant is one or more of magnesium stearate, Pulvis Talci, polyglycol ether class.
Wherein, described tablet is preferably coated tablet, the polyglycol ether stomach dissolution type thin film also containing 0.2～4 weight portion
Coating powder.
Circle bud Cillium of the present invention, inulin and pueraria root powder broadly fall into existing new resource food, can be in city
Buy on.
Beneficial effect：The loosening bowel to relieve constipation dietary fiber that the present invention provides, with circle bud Cillium, inulin and pueraria root powder be
Raw material, after superfine communication technique, each group divide between mutual synergism, then add food stage adjuvant make solid granules,
Capsule and tablet.Proportioning raw materials selected by the present invention meet modern health preserving principle, and scientific formulation rationally, can substantially shorten row
Just the time, promote the motion of small intestinal, increase feces and discharge quantity and defecation weight, have improve human intestines and stomach's function, intestine moistening is led to
Just, the effects such as regulating intestinal canal health, and good mouthfeel, unique flavor.The method is circle bud Semen Plantaginiss and the deep processing of inulin carries
Supply new developing direction, improve loosening bowel to relieve constipation dietary fiber deep processing production technology level, abundant loosening bowel to relieve constipation dietary fiber
Product variety, problem present in effectively solving loosening bowel to relieve constipation dietary fiber technology of preparing.
Specific embodiment
With reference to embodiment, the present invention is illustrated：
Embodiment 1：Prepared by loosening bowel to relieve constipation dietary fiber solid granules
Weigh circle 850 grams of the Cillium of bud after superfine communication technique, 120 grams of inulin, 30 grams of pueraria root powder, stevioside
2 grams, mixing 25-40 minute in 3 grams of input mixers of apple essence, obtain powder mixture after being sufficiently mixed, obtain final product intestine moistening and lead to
Just dietary fiber solid granules 1#.
Embodiment 2：Loosening bowel to relieve constipation dietary fiber solid granules two are standby
Weigh circle 700 grams of the Cillium of bud after superfine communication technique, 200 grams of inulin, 100 grams of pueraria root powder, xylose
25 grams of alcohol, mixing 25-40 minute in 2 grams of input mixers of vanilla, obtain powder mixture after being sufficiently mixed, obtain final product intestine moistening
Relieving constipation dietary fiber solid granules 2#.
Embodiment 3：Prepared by loosening bowel to relieve constipation dietary fiber capsule
Weigh circle 900 grams of the Cillium of bud after superfine communication technique, 90 grams of inulin, 10 grams of pueraria root powder, stearic acid
Mixing 25-40 minute in 20 grams of input mixers of magnesium, mix homogeneously,
Will be above-mentioned according to implant weight needed for every capsule) mixture is filled into capsulae vacuuses, makes 2500 glue
Capsule.
Embodiment 4：Prepared by loosening bowel to relieve constipation dietary fiber capsule
Weigh circle 700 grams of the Cillium of bud after superfine communication technique, 200 grams of inulin, 100 grams of pueraria root powder, Hard Fat
Mixing 25-40 minute in sour 50 grams of input mixers of magnesium, mix homogeneously,
Will be above-mentioned according to implant weight needed for every capsule) mixture is filled into capsulae vacuuses, makes 2500 glue
Capsule.
Embodiment 5：Prepared by loosening bowel to relieve constipation dietary fiber tablet
Weigh circle 850 grams of the Cillium of bud after superfine communication technique, 120 grams of inulin, 30 grams of pueraria root powder, crystallite is fine
600 grams of dimension element, 10 grams of low-substituted hydroxypropyl cellulose, mixing 25-40 minute in 50 grams of input mixers of magnesium stearate, mixing is all
Even, direct through tablet agent) it is pressed into the piece of 0.5 grammes per square metre；By polyglycol ether stomach dissolution type film coating powder, 10 grams are dissolved in ethanol,
Make it dispersed；The piece weighing up is put in coating pan, solution in above-mentioned steps is uniformly sprayed on piece, obtains final product, preparation
Become 3200.
Will be above-mentioned according to implant weight needed for every capsule) mixture is filled into capsulae vacuuses, makes 2500 glue
Capsule.
Embodiment 6：Prepared by loosening bowel to relieve constipation dietary fiber tablet
Weigh circle 700 grams of the Cillium of bud after superfine communication technique, 200 grams of inulin, 10 grams of pueraria root powder, ethyl is fine
200 grams of dimension element, 100 grams of cross-linking sodium carboxymethyl cellulose, mixing 25-40 minute in 50 grams of input mixers of Pulvis Talci, mixing is all
Even, direct through tablet agent) it is pressed into the piece of 0.5 grammes per square metre；By polyglycol ether stomach dissolution type film coating powder, 10 grams are dissolved in ethanol,
Make it dispersed；The piece weighing up is put in coating pan, solution in above-mentioned steps is uniformly sprayed on piece, obtains final product, preparation
Become 3200.
Using identical test method and condition, will be each former with compositionss for loosening bowel to relieve constipation dietary fiber of the present invention
The folk prescription of material carries out effect contrast test, also carries out work(to the raw material in compositionss in the sample that different ratio ratio obtains simultaneously
Effect contrast test.
The recipe determination of experimental example 1 loosening bowel to relieve constipation dietary fiber solid granules and the effect experiment improving constipation are research circle
Luxuriant Cillium and the Constipation to enterokinesia inhibition mice for the inulin composition with functions, using similar to mankind's constipation
The more normal animal model of animal model be preferred, therefore adopt the temporary suppression of the fragrant promise vinegar in diarrhea compound recipe ground little in our current research
The Intestinal motility of Mus.Also use pigment flow method in this research, select the mice enterokinesia that can measure intestinal propulsion experiment
Inhibition, with the activated carbon powder of black as indicator, with prepared Chinese ink intestinal advance distance as index.Using identical test
Method and condition, the folk prescription of loosening bowel to relieve constipation dietary fiber of the present invention and raw material each in compositionss is carried out effect to having a competition
Test, also in the sample that different ratio ratio obtains, effect contrast test is carried out to the raw material in compositionss simultaneously.
First, experimental condition：
1st, material and method
1.1 sample：
1), folk prescription sample：
A group：Circle 10.0 parts of Cillium of bud, 0.02 part of stevioside；
B group：10.0 parts of inulin, 0.02 part of stevioside；
C group：10.0 parts of pueraria root powder, 0.02 part of stevioside；
2), compound recipe sample：
D group：Circle 7.0 parts of Cillium of bud, 2.0 parts of inulin, 1.0 parts of pueraria root powder, 0.02 part of stevioside；
E group：Circle 9.0 parts of Cillium of bud, 0.5 part of inulin, 0.5 part of pueraria root powder, 0.02 part of stevioside；
F group：Circle 8.5 parts of Cillium of bud, 1.2 parts of inulin, 0.3 part of pueraria root powder, 0.02 part of stevioside；
1.2 experimental animal：ICR healthy male mice group, totally 120, body weight 18-22g, secondary animal room is raised.Animal
By body weight random packet, every group 10, during packet, body weight is carried out with harmonious inspection.Experimental animal is quarantined observation 7 before the test
My god, in whole process of the test, in secondary animal room, animal freely ingests and drinks water for animal feeding, laboratory temperature 20～25
DEG C, humidity 40～70%.
1.3 instruments and reagent：Operating scissorss, ophthalmic tweezers, ruler, balance, activated carbon powder, Radix Acaciae senegalis, the fragrant promise in compound recipe ground
Ester (Changzhou Kang Pu).
1.4 groups and dose design：
Test sets 8 groups altogether, that is, blank control group, model control group and 8 sample groups (A group, B group, C group, D group, E group,
F group, F low dose group and F high dose group)；Wherein in sample group, A group, B group, C group, D group, E group, the dosage of F group are
14.2g/kg bw, is equivalent to 10 times of human body taking dose.And the dosage of F low dose group is 0.71g/kg bw,
Be equivalent to 5 times of human body taking dose；The dosage of F high dose group is 28.4g/kg bw, is equivalent to human body and takes agent
20 times of amount.Blank control group and model group give equal-volume distilled water.
1.5 route of administration and administered volume：Gastric infusion, gavage amount is 0.2mL/10g.b.w.
2nd, test method：
2.1 antagonism diphenoxylate suppression Intestinal pushing Experiment on Functions
2.1.1 packet
Take the qualified mice of quarantine, be randomly divided into 10 groups, every group 10, i.e. blank control group, model control group, 8 examinations
Sample group.
2.1.2 the foundation of model
After packet, each group starts to gavage corresponding medicine, and blank control group and model control group animal gavage give equal-volume
Distilled water, once a day, continuous 10 days.Weigh a body weight within every three days in process of the test.After 10 days, each group mice fasting be can't help
Water 16 hours.Model group, 8 sample group gavages give compound diphenoxylate (25mg/kg.bw), and blank group is to distilled water.
2.1.3 the method for index determining
After compound diphenoxylate 0.5 hour, each sample fraction does not give the carbon powder suspension containing corresponding given the test agent, presses
0.2ml/10g.b.w gavage.After 25 minutes, put to death mice and open abdomen, take small intestinal clip upper end from pylorus, the intestinal of lower end to ileocecus
Pipe, small intestinal suspention is vertically in line, and measuring Length of intestine is " total small intestinal length ", is that " prepared Chinese ink pushes away from pylorus to black antiperspirant forward position
Enter length ", calculate ink progradation.The computing formula of ink progradation is as follows：
2.2 antagonism drug induced constipation tests
Take the qualified mice of quarantine, be randomly divided into 10 groups, i.e. blank control group, model control group, 8 sample groups, every group
10, after packet, each dosage group starts to gavage corresponding medicine, the body such as blank control group and model control group animal gavage give
Long-pending distilled water, once a day, continuous 10 days.Weigh a body weight within every three days in process of the test.Water 12 is can't help in last before processing fasting
After hour, in addition to blank control group, other each group gavages give diphenoxylate 25mg/kg, give 1 hour after diphenoxylate, mould
Type group gives carbon powder suspension, and sample group gives the carbon powder suspension containing counter sample, 0.2mL/10g, and every mice is all individually fed,
Observed and recorded every mice defecation time first, 6h defecation grain number and defecation weight.
2.3 experimental data statistics：All data all input EXCEL2013 and carry out statistical analysiss.
3rd, experimental result
The impact of 3.1 pairs of body weight
The impact to Mouse Weight for the table 1
Note：It is compared with model control group, * represents P<0.05, * * represents P<0.01.
By the starting weight of the visible each sample group mice of table 1 result, eventually weight, difference (the P ＞ that compares with model group that there are no significant
0.05).
2.2 antagonism diphenoxylate suppression Intestinal pushing Experiment on Functions
Table 2 is tested to mice Intestinal pushing effect contrast
Note：It is compared with blank control group, △ represents P<0.05, △ △ represents P<0.01；Compare * with model group to represent
P<0.05, * * represents P<0.01.
Table 2 result shows, after giving compound diphenoxylate, model control group ink progradation is significantly lower than blank control group
(P ＜ 0.01), i.e. mice intestinal suppression propulsion model establishment.Each sample group ink progradation significantly improves, sample B group, C group and F
Low dose group is compared with Constipation Model matched group, and difference has significant (P ＜ 0.05)；And Sample A group, D group, E group, F group
Compare with Constipation Model matched group with F high dose group, difference has pole significant (P ＜ 0.01).Show of the present invention multiple
The intestinal inhibitory action that compound causes to diphenoxylate improves significantly effect, and effect is substantially better than each raw material folk prescription experimental group.
2.3 pairs of drug induced constipation tests
The impact to drug induced constipation for the table 3
Note：1 is compared with blank control group,△Represent P<0.05,△△Represent P<0.01.
2 compare * with model control group represents P<0.05, * * represents P<0.01.
Table 3 result shows, after giving diphenoxylate, model group mice first defecation time be obviously prolonged, fecal grains bright
Aobvious minimizing, stool weight substantially reduce, and compare with blank control group, have significant differences (P ＜ 0.01), point out mice just
Secret model is set up.After administration, compare with model group, defecation time substantially shortens first for sample B group, C group and F low dose group, has
Significant difference (P ＜ 0.05).And Sample A group, D group, E group, F group and F high dose group defecation time substantially shortens first, have non-
Often significant difference (P ＜ 0.01), shows that complex of the present invention will than folk prescription to the motion action effect promoting small intestinal
Good.
Compare with model group, sample B group, C group and and F low dose group fecal grains showed increased, have significant difference (P
＜ 0.05), and Sample A group, D group, E group, F group and F high dose group fecal grains showed increased, there is significant differences (P ＜
0.01).Show that complex of the present invention will be good than folk prescription to the effect strengthening feces discharge quantity.Compare with model group,
Sample A group, D group and F low dose group defecation weight substantially increase weight, and have significant difference (P ＜ 0.05), and sample E group, F group and F are high
Dosage group defecation weight substantially increases weight, and has significant differences (P ＜ 0.01).And other each group stool weight has no obvious increasing
Many, there was no significant difference (P>0.05).Show loosening bowel to relieve constipation dietary fiber of the present invention to the effect increasing defecation weight
Will be good than folk prescription.
Comprehensive each result of the test above draws：Loosening bowel to relieve constipation dietary fiber of the present invention causes to diphenoxylate
Intestinal inhibitory action improves significantly effect, and effect is substantially better than each raw material folk prescription experimental group.And intestine moistening of the present invention
Relieving constipation dietary fiber can substantially shorten defecation time, promote the motion effect of small intestinal, strengthen feces and discharge quantity, increase defecation
Weight, effect is substantially better than each raw material folk prescription experimental group.Show that loosening bowel to relieve constipation dietary fiber of the present invention can significantly improve
Constipation.
Below the present invention is disclosed with preferred embodiment, so it is not intended to limiting the invention, all employing equivalents
Or the technical scheme that equivalent transformation mode is obtained, is within the scope of the present invention.
Claims (9)
1. a kind of loosening bowel to relieve constipation dietary fiber, including following components raw material：Circle bud Cillium 70～90 weight portion, inulin 5
～20 weight portions, pueraria root powder 1～10 weight portion；
Described circle bud Cillium, inulin, Lepidinm meyenii Walp powder raw material are all processed through superfine communication technique.
2. loosening bowel to relieve constipation dietary fiber according to claim 1 it is characterised in that：Raw material including following components by weight percent：
Circle bud Cillium 85 weight portion, inulin 12 weight portion, pueraria root powder 3 weight portion.
3. loosening bowel to relieve constipation dietary fiber according to claim 1 and 2 it is characterised in that：Described loosening bowel to relieve constipation dietary fiber
Also include acceptable carrier on food；Dosage form is solid granules, tablet or capsule.
4. loosening bowel to relieve constipation dietary fiber according to claim 3, the formula of solid granules is：
Circle bud Cillium：70～90 weight portions
Inulin：5～20 weight portions
Pueraria root powder：1～10 weight portion
Sweeting agent：0.1～2.5 weight portion
Edible essence 0.01-1.0 part weight portion.
5. loosening bowel to relieve constipation dietary fiber according to claim 3 it is characterised in that：Described sweeting agent is selected from：Stevioside, wood
One or more of sugar alcohol, white sugar, aspartame；
And/or, described edible essence is selected from：In apple essence, flavoring pineapple essence, vanilla, Fructus Citri tangerinae essence, flavoring banana essence
One or more.
6. loosening bowel to relieve constipation dietary fiber according to claim 3, the formula of capsule is：
Circle bud Cillium：70～90 weight portions
Inulin：5～20 weight portions
Pueraria root powder：1～10 weight portion
Magnesium stearate：1～5 weight portion.
7. loosening bowel to relieve constipation dietary fiber according to claim 3, the formula of its tablet is：
Circle bud Cillium：70～90 weight portions
Inulin：5～20 weight portions
Pueraria root powder：1～10 weight portion
Binding agent：20～60 weight portions
Disintegrating agent：1～10 weight portion
Lubricant：1～5 weight portion.
8. loosening bowel to relieve constipation dietary fiber according to claim 5 it is characterised in that：Described adhesive be Microcrystalline Cellulose,
Cross-linking sodium carboxymethyl cellulose, sodium carboxymethyl cellulose, Hypromellose, low-substituted hydroxypropyl cellulose, methylcellulose and
One or more of ethyl cellulose；
And/or, described disintegrating agent is dried starch, carboxymethyl starch sodium, low-substituted hydroxypropyl cellulose, cross-linked carboxymethyl cellulose
One or more of sodium；
And/or, described lubricant is one or more of magnesium stearate, Pulvis Talci, polyglycol ether class.
9. loosening bowel to relieve constipation dietary fiber according to claim 5 it is characterised in that：Described tablet also contains 0.2～4 weight
The polyglycol ether stomach dissolution type film coating powder of part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610833210.8A CN106465946A (en) | 2016-09-19 | 2016-09-19 | A kind of loosening bowel to relieve constipation dietary fiber |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610833210.8A CN106465946A (en) | 2016-09-19 | 2016-09-19 | A kind of loosening bowel to relieve constipation dietary fiber |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106465946A true CN106465946A (en) | 2017-03-01 |
Family
ID=58230281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610833210.8A Pending CN106465946A (en) | 2016-09-19 | 2016-09-19 | A kind of loosening bowel to relieve constipation dietary fiber |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106465946A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107279454A (en) * | 2017-06-20 | 2017-10-24 | 上海交通大学 | A kind of new viscous food compositions and preparation method thereof |
| CN109349604A (en) * | 2018-09-04 | 2019-02-19 | 广州大正新材料科技有限公司 | A kind of weight losing meal-replacing powder with beauty functions |
| CN110089751A (en) * | 2019-04-02 | 2019-08-06 | 大连双迪科技股份有限公司 | Intestines arrange health care product |
| CN112535250A (en) * | 2020-12-28 | 2021-03-23 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | Biological cellulose beverage capable of relaxing bowel and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102362640A (en) * | 2011-10-20 | 2012-02-29 | 仲景林 | Healthcare bread stuffing containing fine plantain powder |
| CN105796662A (en) * | 2016-03-31 | 2016-07-27 | 河南蓝图制药有限公司 | Psyllium seed husk powder and inulin composition |
-
2016
- 2016-09-19 CN CN201610833210.8A patent/CN106465946A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102362640A (en) * | 2011-10-20 | 2012-02-29 | 仲景林 | Healthcare bread stuffing containing fine plantain powder |
| CN105796662A (en) * | 2016-03-31 | 2016-07-27 | 河南蓝图制药有限公司 | Psyllium seed husk powder and inulin composition |
Non-Patent Citations (1)
| Title |
|---|
| 蔡光先: "《超微中药的临床应用与实验研究》", 30 April 2011, 中国中医药出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107279454A (en) * | 2017-06-20 | 2017-10-24 | 上海交通大学 | A kind of new viscous food compositions and preparation method thereof |
| CN109349604A (en) * | 2018-09-04 | 2019-02-19 | 广州大正新材料科技有限公司 | A kind of weight losing meal-replacing powder with beauty functions |
| CN110089751A (en) * | 2019-04-02 | 2019-08-06 | 大连双迪科技股份有限公司 | Intestines arrange health care product |
| CN112535250A (en) * | 2020-12-28 | 2021-03-23 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | Biological cellulose beverage capable of relaxing bowel and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102349553B (en) | Health-care coarse-grain flour, dried noodle, and preparation processes thereof | |
| CN104431741B (en) | Cereal conditioning porridge and making method and application thereof | |
| CN102813114B (en) | Gastrointestinal health preserving pulp and preparation method of gastrointestinal health preserving pulp | |
| CN101103811A (en) | Health food capable of relaxing the bowels | |
| CN105796662A (en) | Psyllium seed husk powder and inulin composition | |
| CN105211687A (en) | A kind of composition and method of making the same and purposes | |
| CN104126790A (en) | Phlegm-dampness constitution health food and preparation method thereof | |
| CN107836640A (en) | A kind of high-fiber high-protein alimentary paste and preparation method thereof | |
| CN102302211B (en) | Health-care beverage | |
| CN106465946A (en) | A kind of loosening bowel to relieve constipation dietary fiber | |
| CN105341641A (en) | Health-care flour capable of reducing blood sugar and preparation method of health-care flour | |
| CN106901367A (en) | The composition and preparation method and purposes of a kind of balance blood sugar | |
| CN109549097A (en) | A kind of health caring noodles with functions of reducing sugar and reducing fat | |
| CN105031042A (en) | Medicinal composition having weight-loss function and application of medicinal composition | |
| CN104322630A (en) | Konjac soda biscuits and production process thereof | |
| CN101564160B (en) | Food for preventing and treating hyperlipemia and hyperglycemia and preparation method thereof | |
| CN106723015A (en) | A kind of health food and its preparation technology with antifatigue and anti-oxidation function | |
| CN105725187A (en) | Blood sugar reducing composition and application in preparation of foods and health-care foods | |
| CN103461756B (en) | Mixed grain rice total nutrient formula food for patient with cancer | |
| CN104957474A (en) | Moringa oleifera composition for reducing blood pressure and preparation method of moringa oleifera composition | |
| CN107802770A (en) | Balance the Chinese medicine and health products of metabolic system radical cure early stage type II diabetes | |
| CN101642207A (en) | Nutritive rice capable of decreasing blood lipid and production technology thereof | |
| CN102090637A (en) | Collagen-containing compound nutritious powder | |
| CN107348350A (en) | A kind of noodles for adjusting blood glucose and preparation method thereof | |
| CN101496568A (en) | Mung bean or pea dietary fiber and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170301 |
|
| RJ01 | Rejection of invention patent application after publication |